91 related articles for article (PubMed ID: 25014496)
1. mTOR inhibition by everolimus in childhood acute lymphoblastic leukemia induces caspase-independent cell death.
Baraz R; Cisterne A; Saunders PO; Hewson J; Thien M; Weiss J; Basnett J; Bradstock KF; Bendall LJ
PLoS One; 2014; 9(7):e102494. PubMed ID: 25014496
[TBL] [Abstract][Full Text] [Related]
2. Primary acute lymphoblastic leukemia cells are susceptible to microtubule depolymerization in G1 and M phases through distinct cell death pathways.
Delgado M; Rainwater RR; Heflin B; Urbaniak A; Butler K; Davidson M; Protacio RM; Baldini G; Edwards A; Reed MR; Raney KD; Chambers TC
J Biol Chem; 2022 Jun; 298(6):101939. PubMed ID: 35436470
[TBL] [Abstract][Full Text] [Related]
3. Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia.
Shojaee S; Caeser R; Buchner M; Park E; Swaminathan S; Hurtz C; Geng H; Chan LN; Klemm L; Hofmann WK; Qiu YH; Zhang N; Coombes KR; Paietta E; Molkentin J; Koeffler HP; Willman CL; Hunger SP; Melnick A; Kornblau SM; Müschen M
Cancer Cell; 2015 Jul; 28(1):114-28. PubMed ID: 26073130
[TBL] [Abstract][Full Text] [Related]
4. Targeting paraptosis in cancer: opportunities and challenges.
Chen F; Tang H; Cai X; Lin J; Xiang L; Kang R; Liu J; Tang D
Cancer Gene Ther; 2024 Mar; 31(3):349-363. PubMed ID: 38177306
[TBL] [Abstract][Full Text] [Related]
5. Correction to "Down regulation of membrane-bound Neu3 constitutes a new potential marker for childhood acute lymphoblastic leukemia and induces apoptosis suppression of neoplastic cells".
Int J Cancer; 2024 Jun; 154(11):E10. PubMed ID: 38372419
[No Abstract] [Full Text] [Related]
6. Ezetimibe Induces Paraptosis through Niemann-Pick C1-like 1 Inhibition of Mammalian-Target-of-Rapamycin Signaling in Hepatocellular Carcinoma Cells.
Yin Y; Wu C; Zhou Y; Zhang M; Mai S; Chen M; Wang HY
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38275586
[TBL] [Abstract][Full Text] [Related]
7. Paraptosis: a unique cell death mode for targeting cancer.
Hanson S; Dharan A; P V J; Pal S; Nair BG; Kar R; Mishra N
Front Pharmacol; 2023; 14():1159409. PubMed ID: 37397502
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma.
Pan S; Meng H; Fan T; Hao B; Song C; Li D; Li N; Geng Q
Front Genet; 2022; 13():900159. PubMed ID: 35664309
[TBL] [Abstract][Full Text] [Related]
9. DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer.
Liu M; Xu C; Qin X; Liu W; Li D; Jia H; Gao X; Wu Y; Wu Q; Xu X; Xing B; Jiang X; Lu H; Zhang Y; Ding H; Zhao Q
Front Oncol; 2022; 12():873649. PubMed ID: 35646704
[TBL] [Abstract][Full Text] [Related]
10. c-MYC-mediated TRIB3/P62
Su MX; Xu YL; Jiang XM; Huang MY; Zhang LL; Yuan LW; Xu XH; Zhu Q; Gao JL; Lu JH; Chen X; Huang MQ; Wang Y; Lu JJ
Acta Pharm Sin B; 2022 Mar; 12(3):1240-1253. PubMed ID: 35530150
[TBL] [Abstract][Full Text] [Related]
11. New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer.
An J; Peng C; Tang H; Liu X; Peng F
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502549
[TBL] [Abstract][Full Text] [Related]
12. Autophagy Triggers Tamoxifen Resistance in Human Breast Cancer Cells by Preventing Drug-Induced Lysosomal Damage.
Actis C; Muzio G; Autelli R
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809171
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of pediatric B-cell acute lymphoblastic leukemia: Molecular pathways and disease treatments.
Huang FL; Liao EC; Li CL; Yen CY; Yu SJ
Oncol Lett; 2020 Jul; 20(1):448-454. PubMed ID: 32565969
[TBL] [Abstract][Full Text] [Related]
14. Targeting mTOR in Acute Lymphoblastic Leukemia.
Simioni C; Martelli AM; Zauli G; Melloni E; Neri LM
Cells; 2019 Feb; 8(2):. PubMed ID: 30795552
[TBL] [Abstract][Full Text] [Related]
15. Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line.
Podshivalova K; Wang EA; Hart T; Salomon DR
Leuk Res; 2018 Nov; 74():1-9. PubMed ID: 30269036
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin reversal of VEGF-C-driven lymphatic anomalies in the respiratory tract.
Baluk P; Yao LC; Flores JC; Choi D; Hong YK; McDonald DM
JCI Insight; 2017 Aug; 2(16):. PubMed ID: 28814666
[TBL] [Abstract][Full Text] [Related]
17. Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer.
Morad SAF; Davis TS; MacDougall MR; Tan SF; Feith DJ; Desai DH; Amin SG; Kester M; Loughran TP; Cabot MC
Biochem Pharmacol; 2017 Apr; 130():21-33. PubMed ID: 28189725
[TBL] [Abstract][Full Text] [Related]
18. Impact of mTOR expression on clinical outcome in paediatric patients with B-cell acute lymphoblastic leukaemia - preliminary report.
Ulińska E; Mycko K; Sałacińska-Łoś E; Pastorczak A; Siwicka A; Młynarski W; Matysiak M
Contemp Oncol (Pozn); 2016; 20(4):291-6. PubMed ID: 27688725
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells.
Li P; Diab S; Yu M; Adams J; Islam S; Basnet SK; Albrecht H; Milne R; Wang S
Oncotarget; 2016 Aug; 7(35):56811-56825. PubMed ID: 27462781
[TBL] [Abstract][Full Text] [Related]
20. Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells.
Lui A; New J; Ogony J; Thomas S; Lewis-Wambi J
BMC Cancer; 2016 Jul; 16():487. PubMed ID: 27421652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
